Allison Institute Scientific Symposium
2026 information available soon
The James P. Allison InstituteTM Fourth Annual Scientific Symposium will take place in fall 2026 at TMC3 Helix Park in Houston, Texas.
This annual gathering brings together thought leaders, researchers, academics and professionals from around the world to share groundbreaking discoveries, foster collaboration and advance the frontiers of science.
Directions and Parking
Address: 7255 Helix Park Ave., Houston, TX 77030
Parking is available in the underground garage at TMC3. Unfortunately, we are unable to provide validation.
UT MD Anderson employees may also take the employee shuttle from their buildings to 1MC and then walk to TMC3. There will be signage outside 1MC directing you to TMC3.
You can enter the building from both sides, but we highly recommend using the main entrance on Helix Park Ave (park entrance), where the registration tables will be located.
Past Symposiums
2025
Allison Institute¡¯s third annual scientific symposium highlighted by panel discussion with five Nobel laureates
- Sessions focused on the latest advances in cancer vaccines, immunotherapy and immunology research
- Symposium featured a panel discussion with five Nobel laureates, moderated by TIME Senior Health Correspondent Alice Park
The?James P. Allison Institute??at Â鶹ӳ»?MD Anderson?Cancer Center hosted its third annual?scientific symposium, ¡°The Multiverse of Mechanistic Processes Impacting Immunity,¡± on Oct. 24 at the TMC3?Collaborative Building in the Texas Medical Center¡¯s Helix Park.?
The symposium, with more than 1,500 attending in person and virtually, featured a panel discussion with five Nobel laureates, three sessions highlighting the latest advances in cancer vaccines, immunotherapy and immunology research, a poster session, and the presentation of awards for scientific achievement and leadership.?
¡°Collaborative efforts are crucial for advancing meaningful breakthroughs in the fields of immunobiology and immunotherapy,¡± said Nobel laureate?, director of the Allison Institute and regental professor and chair of Immunology at MD?Anderson. ¡°We are proud to host this annual symposium and to welcome renowned members of the scientific community. Together, we can make significant progress to fully understand the immune system and move closer toward our mission to end cancer.¡±
The Allison Institute is leading exceptional discovery and translational and clinical?research?to integrate immunobiology across all disciplines. With a comprehensive understanding of the immune system, Allison Institute researchers will accelerate new, synergetic therapies to bring the benefits of?immunotherapy?to all patients.
The symposium opened with remarks from?Allison, , director of scientific programs at the Allison Institute and professor of?Genitourinary Medical Oncology?and Immunology at?MD Anderson, and , president and CEO of the Texas Medical Center. Sharma introduced a special shopping experience, hosted by Houston on Oct. 25, with 15% of net proceeds from all sales benefitting research at the Allison Institute.
Three sessions featured more than 15 leading clinicians and researchers focused on breakthroughs in cancer vaccine and RNA biology, the intersection of biology and chemistry for cancer immunotherapy, and advances in cancer immunology for improving clinical outcomes. Keynote speakers included:
- , Nobel laureate and professor of Genetics at Harvard Medical School??
- , Nobel laureate and Anne T. and Robert M. Bass professor of chemistry at Stanford University
- , associate member of the Immunology program at Memorial Sloan Kettering Cancer Center
- , founder of Sonoma Biotherapeutics and recipient of the?2025 Nobel Prize in Physiology or Medicine
The?highlight of the day was a panel discussion with Allison and four other Nobel laureates?¨C Bertozzi, Ramsdell, Ruvkun, and , professor emeritus at The?Massachusetts Institute of Technology ¨C and moderator?, senior health correspondent at TIME.
The Allison Institute also presented several awards to recognize scientific achievement and leadership. , chief scientific officer at MD Anderson, received the inaugural James P. Allison Institute Catalyst Award for his innovative vision and collaborative scientific leadership.
The symposium poster session featured 91 scientific presentations, and the top three posters were honored. First place was awarded to Mehdi Chaib, Ph.D., second place was awarded to Falk Ponath, Ph.D., and third place was awarded to Annette Wu.?
2024
Allison Institute scientific symposium features spatial biology breakthroughs, $5 million gift to support further efforts
The?James P. Allison Institute??at Â鶹ӳ»?MD Anderson?Cancer Center hosted its second annual scientific symposium, ¡°Immunotherapy in Space and Time: The Tumor Microenvironment,¡± on Oct. 10 at the TMC3?Collaborative Building in the Texas Medical Center¡¯s Helix Park. The symposium, with more than 900 attendees, featured two Nobel laureates and a $5 million gift from the David and Eula Wintermann Foundation to advance the work of the Allison Institute?.
¡°Spatial biology is a rapidly expanding field that offers tremendous new insights into immunobiology that were not possible just a few short years ago. Understanding how immune cells interact with their neighbors and with tumor cells in space and time will enable us to bring forward new strategies to improve immunotherapy outcomes,¡± said Nobel laureate?, director of the Allison Institute and regental professor and chair of?Immunology?at?MD Anderson.?¡°We are proud to host this annual symposium to advance the field, and we are extremely grateful for the support of the Wintermann Foundation to make new breakthroughs possible.¡±
The Allison Institute is leading exceptional discovery, translational and clinical?research?to integrate immunobiology across all disciplines. With a comprehensive understanding of the immune system, Allison Institute researchers will accelerate new, synergetic therapies to bring the benefits of immunotherapy to all patients.
Since its launch, the institute has focused on engaging the top minds in the world to share ideas and accelerate progress. The annual scientific symposium advances that goal by assembling experts from multiple disciplines to share groundbreaking research and build collaborative relationships. This year¡¯s focus on spatial biology and the tumor microenvironment highlights a rapidly emerging and highly impactful theme in the field.
The symposium opened with remarks from?, director of scientific programs at the Allison Institute and professor of Genitourinary Medical Oncology and Immunology at MD Anderson. Following these remarks, Amy Peck, Houston City Council Member for District A, presented Allison and Sharma with a proclamation on behalf of Mayor John Whitmire to name Oct. 10, 2024, as ¡°James P. Allison Institute Day¡± in the city of Houston.
Sessions featured more than 20 leading clinicians and researchers focused on themes from the Allison Institute¡¯s?priority research areas, including keynote presentations from , , , and
A highlight of the event was a conversation between two Nobel laureates ¨C Allison and Bertozzi ¨C and moderator , senior health correspondent at TIME. Park also moderated a fireside chat with MD Anderson President Peter WT Pisters, M.D., and Chief Scientific Officer , together with Allison Institute leaders and researchers.
$5 million gift to fund talent, technology and research
Following the scientific presentations, Jack and Judi Johnson, of Eagle Lake, Texas, presented a $5 million gift to the Allison Institute on behalf of the David and Eula Wintermann Foundation, a private organization dedicated to funding the advancement of medical education and research. The foundation is a long-time supporter of MD Anderson¡¯s mission to end cancer, and this significant investment will enable the Allison Institute to recruit exceptional scientists, to acquire cutting-edge technology and to fund impactful clinical trials.
¡°It was clear to us that the work happening within the Allison Institute has the potential to transform the lives of so many patients,¡± said Johnson, president of the Wintermann Foundation. ¡°Our hope is that, with our support, we can help close the distance from the lab to the clinic so the incredible advancements underway can sooner help more cancer patients and their families.¡±
Through the generosity of the Wintermann Foundation, the Allison Institute will establish and fund multiple researchers, who will be recognized as Wintermann Scholars. The scholars will include early career scientists, established researchers and internationally recognized experts in the fields of immunotherapy, genetics, cancer biology, data science, bioinformatics, spatial profiling or the microbiome. The gift also will support immune monitoring technology and allow for future clinical trial support.
¡°I am grateful to be nine years cancer-free and a recipient of the life-changing immunotherapy advancements made at MD Anderson,¡± said Dewey Stringer, founder of Adopt-a-Scientist-Cure-Cancer and a colleague and longtime friend of Johnson. ¡°This is particularly amazing, considering there was no cure for my cancer. Thanks to Dr. Allison¡¯s brilliance, I am alive today. Supporting the Allison Institute is a no-brainer, and through the Wintermann donation, even more people will be able to benefit from this science.¡±
2023
Allison Institute hosts inaugural scientific symposium
The James P. Allison Institute? at Â鶹ӳ» MD Anderson Cancer Center hosted its inaugural scientific symposium on Nov. 10 at the TMC3 Collaborative Building in the Texas Medical Center¡¯s Helix Park. The event brought together more than 400 leading scientists, including three Nobel laureates, from multiple disciplines to share groundbreaking immunotherapy and immunobiology research.
¡°Our inaugural symposium is an important milestone representing significant progress for the Allison Institute since we launched last year, and we¡¯re energized by the exceptional science shared by our members and colleagues,¡± said Nobel laureate , director of the Allison Institute? and regental professor and chair of Immunology at MD Anderson. ¡°With an incredible environment and amazing collaborators, I look forward to our continued work to advance immunotherapy cures.¡±
The Allison Institute was created to advance exceptional discovery, translational and clinical research that will integrate immunobiology across all disciplines. By gaining a comprehensive understanding of the immune system, the institute aims to lead groundbreaking research that will bring the benefits of immunotherapy to all patients.
The symposium opened with remarks from MD Anderson President Peter WT Pisters, M.D., and Allison, followed by presentations from 13 leading clinicians and scientists focused on themes from the Allison Institute¡¯s priority research areas. Featured speakers included:
- Robert Schreiber, Ph.D.
Andrew M. and Jane M. Bursky Distinguished Professor of Pathology and Immunology
Director, Bursky Center for Human Immunology and Immunotherapy Programs
Washington University School of Medicine
Allison Institute Scientific Advisory Board Co-Chair
- Elaine Mardis, Ph.D.
Co-Executive Director, Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children¡¯s Hospital
Rasmussen Nationwide Foundation Endowed Chair of Genomic Medicine
Professor of Pediatrics, The Ohio State University College of Medicine
Allison Institute Scientific Advisory Board Co-Chair
- Carolyn Bertozzi, Ph.D.
Nobel Prize in Chemistry 2022
Baker Family Director of Stanford ChEM-H
Anne T. and Robert M. Bass Professor of Humanities and Sciences
Professor of Chemical and Systems Biology, Professor of Radiology
Stanford University
- Phillip Sharp, Ph.D.
Nobel Prize in Physiology or Medicine 1993
Emeritus Professor
Member, Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
- Tak Mak, Ph.D.
Senior Scientist
Princess Margaret Cancer Centre
Director, The Campbell Family Institute for Breast Cancer Research
Professor of Medical Biophysics
University of Toronto
- Padmanee Sharma, M.D., Ph.D.
Director of Scientific Programs, Allison Institute
Associate Vice President of Immunobiology
Professor of Genitourinary Medical Oncology and Immunology
MD Anderson
?
¡°The Allison Institute is aligned with MD Anderson¡¯s mission to end cancer, and we are committed to building on the great promise of immunotherapy to improve treatments for millions of patients,¡± Pisters said. ¡°I am certain this inaugural symposium will drive further impact for the Allison Institute. With insights from distinguished scientists from around the world, we are fostering collaboration, inspiration and new ideas that can move immunotherapy forward in unbelievable ways.¡±
?